Beximco Pharma to acquire majority stake in Sanofi Bangladesh Star Business Report Star Business Report
Beximco Pharmaceuticals Ltd, one of the leading drug makers, today said it is going to acquire 54.6 percent stake of Sanofi Bangladesh in its bid to further strengthen its position in the drug market.
It has not disclosed the amount of proposed transaction but said it has signed an agreement to acquire the majority shares of Sanofi Bangladesh, Beximco said in a press release.
Sanofi Group currently holds 54.6 percent shares in the paid-up capital of Sanofi Bangladesh.
Industries ministry holds nearly 25.36 percent and Bangladesh Chemical Industries Corporations holds around 19.96 percent shares of Sanofi Bangladesh.